.jpg)
.png)
All
A few weeks ago, FDA announced that cholesterol-lowering drugs known as statins would have to carry warnings that side effects can include, among other things, possible memory loss. WebMD, April 2, 2012
h3{ margin-bottom:10px; } Advocacy Committee The Advocacy Committee is focused on (1) supporting current relationships with like-minded organizations, (2) identifying opportunities for new relationships with strategic partners to improve the visibility... more
The purpose of the group is to focus on issues facing South Asian patients, determine ways in which this population can fit into NLA educational activities, develop relevant tools, and support the providers in our community in treating these patients. The functions of the South Asian Work Group... more
Thank you for participating in the 21 Day Challenge. Below please find your opportunity to reflect on today's activity. Note: Chapter and Reflection are the only mandatory fields, though the NLA hopes to collect participant demographic data for improvement of DEI within our organization. more
Atherogenic lipoproteins play a critical role in the initiation and progression of vascular atherosclerosis, and decades of research have clearly demonstrated the benefits of lipid-lowering therapy for prevention of atherosclerotic cardiovascular disease (ASCVD) events. However, despite the... more
The National Lipid Association announced on Wednesday its support of the Lipoprotein(a) Foundation’s efforts to promote a new ICD-10 Diagnostic-Code for high Lp(a). The NLA believes the new code will be beneficial in identifying lethal risk factors in patients. To further support this... more
Overview Travel Grants and Awards E-Poster Submission Details FAQs GENERAL Who can submit an abstract? Anyone engaged in clinical practice, research, or education in lipidology or related fields may submit an abstract. Submissions must be made by the presenting author (or a co-author... more
The 2013 Impact Factors were recently released and the Journal of Clinical Lipidology (JCL) saw a significant increase — from 2.741 (2012) to 3.587. The Journal is now ranked 53rd out of 254 journals in its category (pharmacology and pharmacy). “This a very large change in one year... more
Esperion has announced that NEXLETOL™ (bempedoic acid) is now available in pharmacies in the United States. NEXLETOL is an oral, once-daily, tablet indicated as an adjunct to diet and maximally tolerated statin for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH... more